Items
topic_interest is exactly
pharmaceutical
-
2020
COVID-19: Impact on Canada's pharmaceutical and retail pharmacy industry
The coronavirus pandemic has affected Canada’s pharmaceutical and retail pharmacy industry across four main areas: product sourcing and procurement, product launch and distribution, acquisition and access, and treatment and care management. Based on challenges in these areas, this report offers a perspective on potential solutions and considerations. -
2020-10-30
“The Simple Rule That Could Keep COVID-19 Deaths Down” - The Atlantic Monthly
Aside from “flattening the curve” of infections, the longer one avoids contracting COVID-19 also ensures that one will have a higher survival rate. This observation was made by Sarah Zhang, a journalist writing for the Atlantic Monthly who has published several articles concerning the pandemic. In this particular article, Zhang briefly summarizes the reasons why it is better for one to get infected later than sooner, supporting each point with peer-reviewed research and statistical data. According to Zhang, one of the most important reasons why it is better to get infected later than earlier is that medical treatments of COVID-19 have been gradually improving since the pandemic began. For instance, ventilators were initially prescribed for most COVID-19 patients, but they were eventually reserved for extreme cases. Other, less invasive oxygen therapies have been prescribed for milder cases. Similarly, new drugs such as Dexamethasone have been prescribed to more patients as medical knowledge about COVID-19 gradually increased. These innovations are reflected in the slightly reduced death toll. However, Zhang reminds readers that despite these improvements in medical treatments, COVID-19 still has several confounding aspects. Furthermore, several experimental treatments and vaccines are still in testing phases, and will not be viable until well into 2021.